These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 17010466

  • 1. Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice.
    Shimizu K, Ito N, Mita T, Yamada K, Hosokawa-Muto J, Sugiyama M, Minamoto N.
    Virus Res; 2007 Feb; 123(2):154-60. PubMed ID: 17010466
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Amino acid substitutions at positions 242, 255 and 268 in rabies virus glycoprotein affect spread of viral infection.
    Ito Y, Ito N, Saito S, Masatani T, Nakagawa K, Atoji Y, Sugiyama M.
    Microbiol Immunol; 2010 Feb; 54(2):89-97. PubMed ID: 20377742
    [Abstract] [Full Text] [Related]

  • 7. Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy.
    Nakagawa K, Ito N, Masatani T, Abe M, Yamaoka S, Ito Y, Okadera K, Sugiyama M.
    Vaccine; 2012 May 21; 30(24):3610-7. PubMed ID: 22464967
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness.
    Yamaoka S, Ito N, Ohka S, Kaneda S, Nakamura H, Agari T, Masatani T, Nakagawa K, Okada K, Okadera K, Mitake H, Fujii T, Sugiyama M.
    J Virol; 2013 Nov 21; 87(22):12327-38. PubMed ID: 24027304
    [Abstract] [Full Text] [Related]

  • 10. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.
    Ito N, Moseley GW, Blondel D, Shimizu K, Rowe CL, Ito Y, Masatani T, Nakagawa K, Jans DA, Sugiyama M.
    J Virol; 2010 Jul 21; 84(13):6699-710. PubMed ID: 20427527
    [Abstract] [Full Text] [Related]

  • 11. Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein.
    Mebatsion T.
    J Virol; 2001 Dec 21; 75(23):11496-502. PubMed ID: 11689631
    [Abstract] [Full Text] [Related]

  • 12. Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity.
    Morimoto K, Shoji Y, Inoue S.
    Virus Res; 2005 Jul 21; 111(1):61-7. PubMed ID: 15896403
    [Abstract] [Full Text] [Related]

  • 13. Amino acids at positions 273 and 394 in rabies virus nucleoprotein are important for both evasion of host RIG-I-mediated antiviral response and pathogenicity.
    Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, Abe M, Yamaoka S, Sugiyama M.
    Virus Res; 2011 Jan 21; 155(1):168-74. PubMed ID: 20875468
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19.
    Beckert A, Geue L, Vos A, Neubert A, Freuling C, Müller T.
    Microbiol Immunol; 2009 Jan 21; 53(1):16-21. PubMed ID: 19161553
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analyses of cell death mechanisms related to amino acid substitution at position 95 in the rabies virus matrix protein.
    Kojima I, Izumi F, Ozawa M, Fujimoto Y, Okajima M, Ito N, Sugiyama M, Masatani T.
    J Gen Virol; 2021 Apr 21; 102(4):. PubMed ID: 33891533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.